Cargando…

Pembrolizumab-Induced Autoimmune Grade 4 Neutropenia in a Patient With Advanced Bladder Cancer: A Case Report

Neutropenia is amongst the rare, but potentially life-threatening complications of immune checkpoint inhibitors (ICI). Awareness about this dangerous toxicity and its adequate treatment since early detection is of utmost importance. Unfortunately, there are no therapeutical guidelines to deal with n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda Baleiras, Mafalda, Vasques, Carolina, Pinto, Marta, Miranda, Helena, Martins, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754893/ https://www.ncbi.nlm.nih.gov/pubmed/36540515 http://dx.doi.org/10.7759/cureus.31552

Ejemplares similares

Her2 Status Discrepancy Between Core Needle Biopsy and Surgically Resected Mastectomy Specimen: A Clinical Case
por: Vasques, Ana Carolina, et al.
Publicado: (2023)

Paraneoplastic dermatomyositis and prostate cancer: Myopathy regression under cancer-directed therapy
por: Miranda Baleiras, Mafalda, et al.
Publicado: (2021)

Leptomeningeal carcinomatosis in gastric cancer: a case report of a rare yet aggressive entity
por: Baleiras, Mafalda Miranda, et al.
Publicado: (2022)

Therapeutic Futility in Terminal Cancer Patients: A Retrospective and Observational Study
por: Graça, Joana, et al.
Publicado: (2021)

Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer
por: Miranda Baleiras, Mafalda, et al.
Publicado: (2023)

A case of long-term complete remission of locally advanced T4 bladder cancer treated with pembrolizumab
por: Horibe, Yuki, et al.
Publicado: (2021)

An autopsy case of autoimmune meningoencephalitis caused by pembrolizumab
por: Hiraoka, Yuhi, et al.
Publicado: (2022)

Metastatic extramammary paget disease, a remarkable clinical case and a brief review of a rare disease
por: Fernandes, Leonor, et al.
Publicado: (2020)

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review
por: Tan, Qiaoyun, et al.
Publicado: (2022)

Persistent Response and Prolonged Survival Following Pembrolizumab Discontinuation Due to Long-Lasting Autoimmune Colitis in Advanced NSCLC: A Case Report
por: Damato, Angela, et al.
Publicado: (2021)

Multiple Autoimmune Complications After a Single Dose of Pembrolizumab
por: Ahdi, Hardeep S, et al.
Publicado: (2023)

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis
por: Zaremba, Anne, et al.
Publicado: (2021)

Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
por: Alves, Fátima R, et al.
Publicado: (2022)

The Successful Treatment of a Case of Prostate Cancer With Brain Metastasis at Diagnosis
por: Vasques, Ana, et al.
Publicado: (2023)

ErbB4 in the brain: Focus on high grade glioma
por: Pitcher, Jamie-Lee, et al.
Publicado: (2022)

Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
por: Lorusso, Domenica, et al.
Publicado: (2022)

Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
por: Lorusso, Domenica, et al.
Publicado: (2023)

Isolated Chronic and Transient Neutropenia
por: Singh, Navdeep, et al.
Publicado: (2019)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma
por: Silk, Ann W., et al.
Publicado: (2023)

Primary and secondary autoimmune neutropenia
por: Capsoni, Franco, et al.
Publicado: (2005)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
por: Chen, Ya, et al.
Publicado: (2021)

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity
por: Staropoli, Nicoletta, et al.
Publicado: (2023)

Cost-Effectiveness of Lenvatinib Plus Pembrolizumab or Everolimus as First-Line Treatment of Advanced Renal Cell Carcinoma
por: Wang, Ye, et al.
Publicado: (2022)

Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma
por: Nguyen, Charles B., et al.
Publicado: (2022)

Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab
por: Makker, Vicky, et al.
Publicado: (2021)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma
por: Jia, Dong-Dong, et al.
Publicado: (2021)

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study
por: Chen, Ya, et al.
Publicado: (2021)

Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
por: Casanova, Mafalda, et al.
Publicado: (2021)

Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism
por: Litao, Melissa Kaori S., et al.
Publicado: (2021)

Curettage or Resection? A Review on the Surgical Treatment of Low-Grade Chondrosarcomas
por: Castelo, Filipe, et al.
Publicado: (2023)

Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer
por: Patel, Shetal A., et al.
Publicado: (2021)

Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review
por: Wen, Yingmei, et al.
Publicado: (2023)

Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier
por: Abid, Haisam, et al.
Publicado: (2019)

Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid
por: Wang, Jianglin, et al.
Publicado: (2023)

Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia
por: Doumtsis, Petros, et al.
Publicado: (2018)

Villous Tumor of the Urinary Bladder Resembling Low-grade Mucinous Neoplasm of the Appendix
por: Ito, Ayako, et al.
Publicado: (2016)

Is Repeat Transurethral Resection Always Needed in High-Grade T1 Bladder Cancer?
por: Calò, Beppe, et al.
Publicado: (2019)

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China
por: Yang, Wenyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e6dksv6od6oqj9ipjujfcon4bt